THE OPERATING SYSTEM FOR PERSONALIZED THERAPEUTICS Trademark
Trademark Overview
On Saturday, April 19, 2025, a trademark application was filed for THE OPERATING SYSTEM FOR PERSONALIZED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the THE OPERATING SYSTEM FOR PERSONALIZED THERAPEUTICS trademark a serial number of 99145508. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 22, 2025. This trademark is owned by Nome Therapeutics, Inc.. The THE OPERATING SYSTEM FOR PERSONALIZED THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Software as a service (SAAS) services featuring software for drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI)
General Information
| Serial Number | 99145508 |
| Word Mark | THE OPERATING SYSTEM FOR PERSONALIZED THERAPEUTICS |
| Filing Date | Saturday, April 19, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, September 22, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Software as a service (SAAS) services featuring software for drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI) |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, April 19, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Nome Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60614 |
Trademark Events
| Event Date | Event Description |
| Saturday, April 19, 2025 | NEW APPLICATION ENTERED |
| Saturday, April 19, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, August 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 12, 2025 | ASSIGNED TO EXAMINER |
| Monday, September 22, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, September 22, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, September 22, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
